| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ikuo Tsunoda, Li-Qing Kuang, Isaac Z M Igenge, Robert S Fujinam. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. Journal of neuroimmunology. vol 160. issue 1-2. 2005-04-28. PMID:15710465. |
we induced experimental allergic encephalomyelitis (eae) in sjl/j mice, an animal model for multiple sclerosis (ms), using myelin oligodendrocyte glycoprotein (mog)(92-106) peptide, following ultraviolet (uv) irradiation. |
2005-04-28 |
2023-08-12 |
mouse |
| I Kurkowska-Jastrzebska, E Bałkowiec-Iskra, I Joniec, T Litwin, A Członkowski, A Członkowsk. Immunization with myelin oligodendrocyte glycoprotein and complete Freund adjuvant partially protects dopaminergic neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage in mouse model of Parkinson's disease. Neuroscience. vol 131. issue 1. 2005-04-25. PMID:15680707. |
c57bl mice were immunized with either myelin oligodendrocyte glycoprotein (mog) 35-55 combined with complete freund adjuvant (cfa), or cfa alone. |
2005-04-25 |
2023-08-12 |
mouse |
| Cecilia B Marta, Michael B Montano, Christopher M Taylor, Ava L Taylor, Rashmi Bansal, Steven E Pfeiffe. Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. The Journal of biological chemistry. vol 280. issue 10. 2005-04-19. PMID:15634682. |
in particular, antibodies to myelin oligodendrocyte glycoprotein (mog) are elevated in multiple sclerosis patients, and they have been implicated as mediators of demyelination. |
2005-04-19 |
2023-08-12 |
Not clear |
| Andreas Bitsch, Alexander Dressel, Kathrin Meier, Timon Bogumil, Florian Deisenhammer, Hayrettin Tumani, Bernd Kitze, Sigrid Poser, Frank Webe. Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b. Journal of neurology. vol 251. issue 12. 2005-03-29. PMID:15645350. |
we conducted an open-labeled clinical trial of interferon beta-1b (ifnb) treatment in 20 patients with primary progressive multiple sclerosis (ppms) and longitudinally monitored autoantibodies against double-stranded dna (dsdna), thyroid peroxidase (tpo),myelin basic protein (mbp), myelin oligodendrocyte glycoprotein (mog), synapsin and s-100b. |
2005-03-29 |
2023-08-12 |
Not clear |
| Shinya Hirata, Satoru Senju, Hidetake Matsuyoshi, Daiki Fukuma, Yasushi Uemura, Yasuharu Nishimur. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. Journal of immunology (Baltimore, Md. : 1950). vol 174. issue 4. 2005-03-29. PMID:15699115. |
in the current study, we tested a strategy to prevent eae by pretreatment of mice with genetically modified dendritic cells (dc) presenting myelin oligodendrocyte glycoprotein (mog) peptide in the context of mhc class ii molecules and simultaneously expressing trail or programmed death-1 ligand (pd-l1). |
2005-03-29 |
2023-08-12 |
mouse |
| Cécile Besson Duvanel, Florianne Monnet-Tschudi, Olivier Braissant, Jean-Marie Matthieu, Paul Honegge. Tumor necrosis factor-alpha and alphaB-crystallin up-regulation during antibody-mediated demyelination in vitro: a putative protective mechanism in oligodendrocytes. Journal of neuroscience research. vol 78. issue 5. 2005-02-28. PMID:15478179. |
differentiated aggregate cultures of rat telencephalon were subjected to demyelination by exposure to antibodies against myelin oligodendrocyte glycoprotein (mog) and complement. |
2005-02-28 |
2023-08-12 |
rat |
| Mandy L Ford, Brian D Evavol. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. European journal of immunology. vol 35. issue 1. 2005-02-23. PMID:15593305. |
here, we provide evidence for the existence of mouse cd8(+) t cells that are specific for an epitope of the myelin oligodendrocyte glycoprotein (mog). |
2005-02-23 |
2023-08-12 |
mouse |
| Ricarda Diem, Muriel B Sättler, Doron Merkler, Iris Demmer, Katharina Maier, Christine Stadelmann, Hannelore Ehrenreich, Mathias Bäh. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain : a journal of neurology. vol 128. issue Pt 2. 2005-02-22. PMID:15601662. |
after immunization with myelin oligodendrocyte glycoprotein (mog), animals were randomly assigned to six treatment groups receiving different combinations of erythropoietin and methylprednisolone, or respective monotherapies. |
2005-02-22 |
2023-08-12 |
rat |
| Gwyneth Zai, Yarema B Bezchlibnyk, Margaret A Richter, Paul Arnold, Eliza Burroughs, Cathy L Barr, James L Kenned. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 129B. issue 1. 2005-02-16. PMID:15274043. |
myelin oligodendrocyte glycoprotein (mog) gene is associated with obsessive-compulsive disorder. |
2005-02-16 |
2023-08-12 |
Not clear |
| Gwyneth Zai, Yarema B Bezchlibnyk, Margaret A Richter, Paul Arnold, Eliza Burroughs, Cathy L Barr, James L Kenned. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 129B. issue 1. 2005-02-16. PMID:15274043. |
genes involved in immune response therefore represent possible candidate genes for ocd, including the myelin oligodendrocyte glycoprotein (mog) gene, which plays an important role in mediating the complement cascade in the immune system. |
2005-02-16 |
2023-08-12 |
Not clear |
| Thomas P Finn, Richard E Jones, Cathleen Rich, Rony Dahan, Jason Link, Chella S David, Yuan K Chou, Halina Offner, Arthur A Vandenbar. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes. Journal of neuroscience research. vol 78. issue 1. 2005-02-07. PMID:15372502. |
we found that tg drb1*1502 mice had moderate to strong t-cell responses to several myelin peptides with favorable drb1*1501 binding motifs, notably myelin oligodendrocyte glycoprotein (mog)-35-55 (which was also encephalitogenic), proteolipid protein (plp)-95-116, and mog-194-208, as well as other plp and mog peptides. |
2005-02-07 |
2023-08-12 |
mouse |
| Catherine Uyttenhove, Berenice Arendse, Vincent Stroobant, Frank Brombacher, Jacques Van Snic. Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. European journal of immunology. vol 34. issue 12. 2005-02-03. PMID:15549728. |
myelin oligodendrocyte glycoprotein (mog)-induced disease in c57bl/6 mice was also significantly inhibited. |
2005-02-03 |
2023-08-12 |
mouse |
| Hideki Kato, Atsushi Ito, Jun Kawanokuchi, Shijie Jin, Tetsuya Mizuno, Kosei Ojika, Ryuzou Ueda, Akio Suzumur. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. Multiple sclerosis (Houndmills, Basingstoke, England). vol 10. issue 6. 2005-01-24. PMID:15584490. |
when administrated intraperitoneally every other day after immunization with myelin oligodendrocyte glycoprotein (mog) peptide 35-55, pacap ameliorated both the clinical and pathological manifestations of eae ex vivo examination revealed a significant inhibition of mog35-55-specific th1 response in mice treated with pacap. |
2005-01-24 |
2023-08-12 |
mouse |
| Renato Mantegazza, Piercarlo Cristaldini, Pia Bernasconi, Fulvio Baggi, Rosetta Pedotti, Ilaria Piccini, Nerina Mascoli, Loredana La Mantia, Carlo Antozzi, Ornella Simoncini, Ferdinando Cornelio, Clara Milanes. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. International immunology. vol 16. issue 4. 2005-01-14. PMID:15039386. |
several myelin proteins may be encephalitogenic, including myelin basic protein, proteolipid protein and myelin oligodendrocyte glycoprotein (mog), the latter being expressed on the external layer of myelin sheaths and hence accessible to antibody attack. |
2005-01-14 |
2023-08-12 |
Not clear |
| Yuan K Chou, Nicole Culbertson, Cathleen Rich, Dorian LaTocha, Abigail C Buenafe, Jianya Huan, Jason Link, J M Wands, Willi K Born, Halina Offner, Dennis N Bourdette, Gregory G Burrows, Arthur A Vandenbar. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice. Journal of neuroscience research. vol 77. issue 5. 2004-12-22. PMID:15352213. |
thus, we perpetuated myelin oligodendrocyte glycoprotein (mog)-35-55 peptide-specific t cells obtained from immunized hla-drb1*1501-transgenic (tg) mice by somatic fusions with bw5147 thymoma cells or bw5147 t-cell receptor (tcr) alpha(-)beta(-) variant (bw5147 variant) cells. |
2004-12-22 |
2023-08-12 |
mouse |
| V Lampasona, D Franciotta, R Furlan, S Zanaboni, R Fazio, E Bonifacio, G Comi, G Martin. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology. vol 62. issue 11. 2004-12-20. PMID:15184621. |
the authors used a liquid-phase radiobinding assay to measure serum anti-myelin oligodendrocyte protein (mog) immunoglobulin (ig) g in 87 patients with multiple sclerosis (ms), in 12 patients with encephalomyelitis, and in 47 healthy subjects. |
2004-12-20 |
2023-08-12 |
human |
| A J Crang, J M Gilson, W-W Li, W F Blakemor. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS. The European journal of neuroscience. vol 20. issue 6. 2004-12-20. PMID:15355312. |
we recently published evidence that a subpopulation of myelin oligodendrocyte glycoprotein (mog)-expressing cells in the adult rat spinal cord co-expressed molecules previously considered to be restricted to oligodendrocyte progenitors [g. li et al. |
2004-12-20 |
2023-08-12 |
rat |
| A J Crang, J M Gilson, W-W Li, W F Blakemor. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS. The European journal of neuroscience. vol 20. issue 6. 2004-12-20. PMID:15355312. |
our studies indicate that the adult rat cns contains a significant number of oligodendrocyte precursors that express mog and galactocerebroside, molecules previously considered restricted to mature oligodendrocytes. |
2004-12-20 |
2023-08-12 |
rat |
| G Li, W F Blakemor. The number of cells expressing the myelin-supporting oligodendrocyte marker PLP-exon 3b remains unchanged in Wallerian degeneration. Journal of neurotrauma. vol 21. issue 8. 2004-12-02. PMID:15319003. |
axons were disrupted at t13 and the number of labelled cells in the dorsal funiculi counted at t12, 4 days and 2, 4, and 8 weeks after injury using riboprobes to exon-3b of the plp gene whose expression is considered to restricted to myelin-supporting oligodendrocytes, pdgfralpha which is regarded as a marker of oligodendrocyte precursors, and mog a marker previously used to identify myelin-supporting oligodendrocytes. |
2004-12-02 |
2023-08-12 |
Not clear |
| S D Smith, P M Kelley, J W Askew, D M Hoover, K E Deffenbacher, J Gayán, A M Brower, R K Olso. Reading disability and chromosome 6p21.3: evaluation of MOG as a candidate gene. Journal of learning disabilities. vol 34. issue 6. 2004-12-01. PMID:15503566. |
the myelin oligodendrocyte glycoprotein (mog) gene, which maps to this region, was selected as a candidate. |
2004-12-01 |
2023-08-12 |
Not clear |